GTI-2040
2040AML201
Phase 2 mab completed
Quick answer
GTI-2040 for Acute Myeloid Leukemia is a Phase 2 program (mab) at Aptose Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aptose Biosciences
- Indication
- Acute Myeloid Leukemia
- Phase
- Phase 2
- Modality
- mab
- Status
- completed